BioWin s'investit dans NeMs4BIO, un démo-case qui vise à répondre aux défis de l’intégration microfluidique dans divers domaines comme le MedTech et le biomanufacturing.


Hemogenyx is a pre-clinical stage biopharmaceutical group ( developing new medicines and treatments to bring the curative power of bone marrow transplantation to a greater number of patients suffering from otherwise incurable life-threatening diseases.


As a trusted R&D partner of companies, start-ups and academia, research and innovation are in our DNA.
We combine our longstanding leadership in microchip technology with in-depth expertise in software and ICT to lay the foundation of a more personalized healthcare, smarter cities, cleaner energy and more efficient mobility, logistics and manufacturing solutions.

We are a single point of contact for innovators and entrepreneurs who want to explore the potential of advanced technologies.

Janssen Pharmaceutica

Janssen Pharmaceutica NV is part of the Janssen Pharmaceutical Companies of Johnson & Johnson. 
At the Janssen Pharmaceutical Companies of Johnson & Johnson, we are working to create a world without disease. Transforming lives by finding new and better ways to prevent, intercept, treat and cure disease inspires us. We bring together the best minds and pursue the most promising science. 
We are Janssen. We collaborate with the world for the health of everyone in it. 


​​​​​​​Pour relever les défis du secteur de la BioProduction, des thérapies cellulaires et de la médecine régénérative, 4 Centres de formation, 2 universités et le pôle de compétitivité BIOWIN ont décidé d’allier leurs expériences et expertises, leur veille, leur réseau et leurs infrastructures, afin de proposer au travers du projet 4Cells, entre 2016 et 2019, un programme complet de formations (« one stop shopping ») en culture cellulaire
S'abonner à Bioproduction